Condition category
Nervous System Diseases
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status

Plain English Summary

Not provided at time of registration

Trial website

Contact information



Primary contact

Dr Michael Barnes


Contact details

Newcastle City Health NHS Trust
Hunters Moor Rehabilitation Centre
Hunters Road
Newcastle upon Tyne
United Kingdom
+44 (0)191 261 0895

Additional identifiers

EudraCT number number

Protocol/serial number

NYRHA WJML r135/05292

Study information

Scientific title


Study hypothesis

A properly trained outreach nurse practitioner can provide a service that is as good as or better than that provided at a hospital outpatient clinic for people with chronic neurological disability.
The pilot population that is to be used to test this hypothesis is individuals with Parkinson's disease and dystonia attending Hunters Moor Regional Rehabilitation Centre in Newcastle upon Tyne. All patients attending the movement disorder clinic at Hunters Moor will be eligible for participation in the study.
We anticipate the hypothesis will be proven and that a properly trained nurse practitioner is able to provide a more satisfactory support service for people with the pilot condition both from the patients and general practitioners perspectives. If the hypothesis is proven the project will benefit the NHS as the patient will not need to make unnecessary journeys to hospital, the primary care team will be involved more effectively in the management of the individual, the specialist will see individuals at the time when such referral is required and the purchaser should get better value for money.

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet


Parkinson's disease


After informed consent patients will be randomly divided into two groups with approximately 75 individuals in each group.

1. Standard attendance of outpatients
This group will continue to attend regular outpatient assessment at Hunters Moor as previously.

2. Visited at home by an outreach nurse practitioner
This group will not attend outpatients but will be visited at home by an outreach nurse practitioner. The group will have regular access to the nurse practitioner who will act a primary contact point for the disabled person and the family. The nurse practitioner will be responsible for liaison with the general practitioner and primary care team and for referral to the hospital consultant and members of the multi-disciplinary rehabilitation team as necessary. The consultant and multi-disciplinary team members will be able to assess the client and carer either at home or in the hospital. The nurse practitioner, within agreed protocols, would advise the patient on adjusting drug dosages and be responsible for the administration of botulinum toxin injections for individuals with dystonia.
The practitioner will provide educational material, advice and ongoing support for the patient and carer.

Intervention type



Not Specified

Drug names

Primary outcome measure

The effectiveness of this model of care will be assessed by a number of means including
1. Assessment of disability status measured by a number of appropriate scales
1.1. general practitioner and primary care team satisfaction questionnaires
1.2. comparison of attendances at hospital and general practitioner
1.3. record of complications
1.4. record of drug and other medical management employed during the study period
2. Satisfaction questionnaires will be administered to the patient and carer and their psychological status will also be measured using the General Health Questionnaire.
3. A brief questionnaire will be designed that records the extent and level of knowledge and understanding of the disease and associated disabilities. This questionnaire will be administered to the client and carer.
4. An economic analysis will also be undertaken of the costs involved in both arms of the study.

Secondary outcome measures

Not provided at time of registration

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Patients attending the movement disorder clinic at Hunters Moor
2. Being treated for Parkinson's and dystonia
3. Informed consent

Participant type


Age group

Not Specified


Not Specified

Target number of participants

Not provided at time of registration

Participant exclusion criteria

Does not match inclusion criteria

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

Newcastle City Health NHS Trust
Newcastle upon Tyne
United Kingdom

Sponsor information


NHS R&D Regional Programme Register - Department of Health (UK)

Sponsor details

The Department of Health
Richmond House
79 Whitehall
United Kingdom
+44 (0)20 7307 2622

Sponsor type




Funder type


Funder name

NHS Executive Northern and Yorkshire (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Basic results (scientific)

Publication list

1. 2001 results in

Publication citations

  1. Results

    Whitaker J, Butler A, Semlyen JK, Barnes MP, Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service., Arch Phys Med Rehabil, 2001, 82, 4, 480-484, doi: 10.1053/apmr.2001.21843.

Additional files

Editorial Notes